Addiction Treatment Outcome Monitoring Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-10-04

Study Completion Date

2021-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This research evaluates a tool designed for measurement-based care in addiction treatment. Patients in addiction treatment will be invited to complete weekly measures indicating treatment progress and goals. For half the patients, their addiction treatment clinician will be able to view their weekly progress and goals via a secure dashboard. The research will test the feasibility and acceptability of the measurement-based care tool and will evaluate its impact on within-session discussion topics and clinical outcome measures.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Mindfulness Based Relapse Prevention: Efficacy and Mechanisms

NCT01159535

Substance Use Disorders

COMPLETED PHASE1/PHASE2

Brief Intervention in Primary Care for Problem Drug Use and Abuse

NCT00877331

Substance-Related Disorders

COMPLETED NA

Brief Interventions for Drop-out Re-engagement

NCT00350571

Substance Abuse

COMPLETED PHASE1

Motivational Enhancement to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1

NCT00032981

Substance-Related Disorders

COMPLETED PHASE3

Motivational Interviewing to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1

NCT00032994

Substance-Related Disorders

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alcohol Use Disorder Substance Use Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Non-randomized two-arm clinical trial.

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Measurement-only

Patients will complete weekly measures of treatment progress and goals; however, the information from these measures will not be shared with clinicians or patients.

Group Type ACTIVE_COMPARATOR

Measurement

Intervention Type OTHER

The measurement system collects information about patients' treatment progress and goals in key areas that are associated with long-term clinical outcomes (e.g., substance use, craving, coping skills, self-efficacy, life satisfaction, depression). Patients complete the measure up to once per week for up to six months.

Measurement and feedback

Patients will complete weekly measures of treatment progress and goals; the information from these measures will be shared with clinicians.

Group Type EXPERIMENTAL

Measurement

Intervention Type OTHER

The measurement system collects information about patients' treatment progress and goals in key areas that are associated with long-term clinical outcomes (e.g., substance use, craving, coping skills, self-efficacy, life satisfaction, depression). Patients complete the measure up to once per week for up to six months.

Feedback

Intervention Type OTHER

The feedback system is a web-based dashboard that displays current and historical results in each of the outcome and goal domains that is measured; it is available to addiction treatment clinicians who are working with patients enrolled in the study.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Measurement

The measurement system collects information about patients' treatment progress and goals in key areas that are associated with long-term clinical outcomes (e.g., substance use, craving, coping skills, self-efficacy, life satisfaction, depression). Patients complete the measure up to once per week for up to six months.

Intervention Type OTHER

Feedback

The feedback system is a web-based dashboard that displays current and historical results in each of the outcome and goal domains that is measured; it is available to addiction treatment clinicians who are working with patients enrolled in the study.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. At least 18 years old.
2. Self-reports that they are a patient at Harborview Mental Health and Addiction Services (HMHAS) clinic.
3. Self-reports that they are receiving services at HMHAS clinic for an alcohol or drug-related concern.
4. Has a smartphone with a working phone number and a mobile plan that allows text messages and internet connection.
5. AUDIT-C score indicates past-year hazardous drinking (summed score is at least 3 or 4 for women or men, respectively), or self-reports any drug use for non-medical reasons in the past year.
6. Does not anticipate moving away from the Seattle area within 6 months.
7. Does not anticipate becoming incarcerated in next 6 months.
8. Able to speak and read English (based on self-report).
9. Must be receiving clinical services from an HMHAS clinician who is also participating in the study, which will be evidenced by having at least 3 appointments with a participating HMHAS clinician that were either completed within the past three months or are scheduled to occur within the next three months, verified by the electronic health record.